Hakutulokset - Axel Finckh

Tarkenna hakua
  1. 1
    Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis

    Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis Tekijä Axel Finckh

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    The impact of obesity on the development and progression of rheumatoid arthritis

    The impact of obesity on the development and progression of rheumatoid arthritis Tekijä Axel Finckh, Carl Turesson

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

    Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review Tekijä Andrea Rubbert‐Roth, Axel Finckh

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study

    The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study Tekijä Axel Finckh, Silvia Dehler, Cem Gabay

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment

    Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment Tekijä Axel Finckh, Hyon K. Choi, Frederick Wolfe

    Julkaistu 2006
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study

    The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study Tekijä Diego Kyburz, Cem Gabay, BA Michel, Axel Finckh

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry

    Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry Tekijä Cem Gabay, Myriam Riek, Almut Scherer, Axel Finckh

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Cigarette smoking and radiographic progression in rheumatoid arthritis

    Cigarette smoking and radiographic progression in rheumatoid arthritis Tekijä Axel Finckh, Silvia Dehler, Karen H. Costenbader, Cem Gabay

    Julkaistu 2007
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis

    Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network... Tekijä Felicity Buckley, Axel Finckh, T. Huizinga, F. Dejonckheere, Jeroen P. Jansen

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis

    Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis Tekijä Kim Lauper, Delphine S. Courvoisier, Paola Chevallier, Axel Finckh, Cem Gabay

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study

    Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study Tekijä Burkhard Möller, Almut Scherer, Frauke Förger, Peter M. Villiger, Axel Finckh

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    The role of female hormonal factors in the development of rheumatoid arthritis

    The role of female hormonal factors in the development of rheumatoid arthritis Tekijä D. Alpizar-Rodriguez, Nicola Pluchino, G. Canny, Cem Gabay, Axel Finckh

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease

    Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease Tekijä Saskia Ditisheim, Nicolas Fournier, Pascal Juillerat, Valérie Pittet, Pierre Michetti, Cem Gabay, Axel Finckh

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort

    Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort Tekijä R Mueller, T. Kaegi, Axel Finckh, Sarah R. Haile, Hendrik Schulze‐Koops, J. von Kempis

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis

    Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis Tekijä Sophie Martin Du Pan, Silvia Dehler, Adrian Ciurea, Hans‐Rudolf Ziswiler, Cem Gabay, Axel Finckh

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Do synovial leptin levels correlate with pain in end stage arthritis?

    Do synovial leptin levels correlate with pain in end stage arthritis? Tekijä Anne Lübbeke, Axel Finckh, Gábor J. Puskás, Domizio Suvà, Alexandre Lädermann, Sylvette Bas, Daniel Fritschy, Cem Gabay, Pierre Hoffmeyer

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

    Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an a... Tekijä Axel Finckh, Adrian Ciurea, Laure Brulhart, Burkhard Möller, Ulrich A. Walker, D. Courvoisier, Diego Kyburz, Jean Dudler, Cem Gabay

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women

    Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women Tekijä Axel Finckh, Glinda S. Cooper, Lori B. Chibnik, Karen H. Costenbader, Julie Watts, Helen Pankey, Patricia A. Fraser, Elizabeth W. Karlson

    Julkaistu 2006
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    <i>Prevotella copri</i> in individuals at risk for rheumatoid arthritis

    <i>Prevotella copri</i> in individuals at risk for rheumatoid arthritis Tekijä D. Alpizar-Rodriguez, Till Robin Lesker, Achim Gronow, Benoît Gilbert, Elena Raemy, Céline Lamacchia, Cem Gabay, Axel Finckh, Till Strowig

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

    Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis Tekijä Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mähler, Chelsea Bentow, Axel Finckh, Cem Gabay, Michael J. Nissen

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: